Ventritex Cadence reprogramming effort covers 2,000 devices thus far, company reports.
This article was originally published in The Gray Sheet
Executive Summary
VENTRITEX CADENCE ICD RECALL: 2,000 DEVICES REPROGRAMMED to date, Ventritex President and CEO Frank Fischer told analysts Jan. 23 during a conference call. The call, held to review the firm's second quarter financial results, focused primarily on the Sunnyvale, California firm's progress in addressing a pacing malfunction with its Cadence V-110 models that was associated with two cases of "lethal ventricular tachyarrhythmias."